Abstract
Editorials1 May 1982Adverse Effects of Danazol in PregnancyANNE COLSTON WENTZ, M.D.ANNE COLSTON WENTZ, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-96-5-672 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDanazol, an impeded androgen, anabolic steroid, and effective inhibitor of the stimulation by follicle stimulating hormone of folliculogenesis, has achieved a deserved reputation as the preferred medical treatment for endometriosis; in addition, it is effective in treating cystic breast disease and has been used to prevent hereditary angioneurotic edema and excessive menstrual blood loss in ovulating women. In a "Drugs Five Years Later" article published in this issue (1), Madanes and Farber provide a broad view of danazol's place in today's practice. Because the recommended dose of at least 600 mg/d is associated with androgenic and antiestrogenic side effects, the...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
